Rosacea Treatment
Treat rosacea using a phenotype-based approach that targets the specific clinical features present in each patient, rather than relying on traditional subtype classification. 1, 2
Foundation: General Skincare Measures
All patients with rosacea require baseline skincare regardless of specific features 1, 2:
- Use broad-spectrum sunscreen with SPF 30 or higher daily 1, 2
- Apply gentle cleansers and moisturizers 1, 2
- Avoid identified trigger factors (though RCT evidence for this is limited) 2
Treatment Algorithm by Clinical Feature
For Inflammatory Papules/Pustules
Mild presentations:
- First-line: Topical ivermectin 1% cream 2
- Alternative first-line: Topical azelaic acid 15% gel/foam 1, 2
- Newer option: Encapsulated benzoyl peroxide 5% (shows rapid improvement by week 2) 2
Moderate presentations:
Severe presentations:
- Topical ivermectin 1% cream PLUS oral doxycycline 1
- Alternative: Oral isotretinoin for severe or recalcitrant cases 1, 3
For Persistent Erythema
First-line options:
Additional options for moderate to severe:
For Transient Erythema (Flushing)
Treatment options (note: limited high-quality evidence exists) 1:
For Telangiectasia
Primary treatments:
For Phymatous Changes
Clinically inflamed (active) phyma:
- Oral doxycycline 1
Clinically noninflamed (fibrotic/burnt out) phyma:
For Ocular Rosacea
Mild symptoms:
Moderate to severe symptoms:
- Oral doxycycline 2, 4
- Topical cyclosporine 4
- Ophthalmological referral for all but the mildest cases 1, 2
Combination Therapy Approach
Multiple cutaneous features can and should be treated simultaneously with multiple agents 1, 2:
- Moderate and severe presentations typically require combination treatments 1, 2
- If first-line treatment fails after adequate duration, either switch to an alternative first-line option OR add an additional first-line agent 1, 2
Maintenance Therapy
Use the minimum treatment necessary to maintain control 2:
- Up to two-thirds of patients relapse when treatment is discontinued 2
- Maintenance approach depends on treatment modality and patient preference 1, 2
- Continue treatments for sufficient duration before switching (duration is treatment-specific) 1
Critical Pitfalls to Avoid
Insufficient treatment duration: Many rosacea treatment studies last less than 8 weeks, which may be inadequate to demonstrate full efficacy 2. Give treatments adequate time before declaring failure.
Treating by subtype rather than phenotype: The traditional subtype approach fails to address the full spectrum of presenting features 1, 2. Always identify and treat each specific feature present.
Overlooking ocular manifestations: Ocular rosacea is frequently underdiagnosed and undertreated 2. Specifically ask about eye symptoms including burning, foreign body sensation, photophobia, tearing, and blurred vision 1.
Discontinuing maintenance therapy prematurely: Without ongoing maintenance, most patients will relapse 2. Plan for long-term management from the outset.
Applying azelaic acid to broken or inflamed skin: Due to its low pH, temporary irritation (pruritus, burning, stinging) commonly occurs when applied to broken skin 5. If severe irritation develops, reduce to once-daily application or temporarily discontinue 5.